Adept Wins Prestigious MAME Awards for Outstanding Design and Merchandising
The company's outstanding achievements were recognized in the following categories:
- Best Architectural Design of an Individual Attached Home Plan – Priced over
$1.5 Million
- Award Recipient: Domaine 39 - Penthouse 7002
- Design by: Adept Urban
- Interior Design by: Adept Interiors
- Award Recipient: Domaine 39 - Penthouse
- Design by: Adept Urban
- Interior Design by: Adept Interiors
These awards were presented by a panel of respected judges who dedicated their time to evaluating entries in various categories, including product design, graphics, marketing materials, and overall advertising campaigns. Adept's award-winning work in architectural design and interior merchandising stood out among the field of entrants.
Upon receiving the awards, Adept CEO
Adept Development, Architecture, and Construction is known for its strategic approach to real estate development, focusing on transparency, efficiency, and environmental responsibility. The company integrates key Environmental, Social, and Governance (ESG) principles into its business practices, aiming to minimize environmental impacts, improve social conditions, and maintain an independent and diverse advisory board.
Adept has been consistently acknowledged by the industry with recognition and awards, showcasing its ongoing commitment to successful projects and excellence in development.
For more information about Adept Development, Architecture, and Construction, please visit www.AdeptUrban.com.
Contact: Ardy Kassakhian Communications Officer at Adept Development
Email: [email protected] Telephone: (818) 434-8076
View original content:https://www.prnewswire.com/news-releases/adept-wins-prestigious-mame-awards-for-outstanding-design-and-merchandising-301976425.html
SOURCE Adept Urban
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pentixapharm Announces Progress of Pivotal Phase 3 PANDA Study; Will Host Third Quarter Webcast on November 12, 2026
- Minghui Pharmaceutical and ASKA Pharmaceutical Enter into Exclusive License Agreement for the IGF-1R Antibody in Japan
- Tetragon Financial Group Limited Announcement of Tender Offer to Purchase $50,000,000 of Tetragon Non-Voting Shares
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share